What Tantum Treats: Main Uses and Benefits

The primary therapeutic role of Tantum (Benzydamine) is relevant for easing symptoms related to inflammatory or irritative states throughout the mouth and throat. This application is suitable when supportive symptom management is appropriate, contributing to easing the overall symptom load during periods of acute symptoms.

This medication is generally applicable within clinical settings that involve acute or disruptive symptom patterns. It is relevant for easing symptomatic discomfort in situations such as pharyngitis, tonsillitis, gingivitis, stomatitis, and the inflammation associated with aphthous ulcers and post-procedural soreness. Applied across domains where additional symptomatic support is needed, the product assists with managing symptoms that interfere with daily comfort, such as those related to difficulty swallowing and localized swelling. In specialized settings, it is considered relevant for easing symptoms that create noticeable physiological strain, such as those associated with oral mucositis.

This medication is used for managing symptoms that create noticeable physiological strain, and may assist with maintaining functional stability when symptoms disrupt routine activities.

---

Quick Fact: Symptomatic Support for Oropharyngeal Pain

Tantum is often used during phases when symptoms become more noticeable and short-term symptomatic assistance is needed to ease the discomfort and swelling associated with inflammatory conditions of the mouth and throat.

Official Eligibility Profile for Tantum (Benzydamine)

This information, based strictly on official regulatory documents, defines the population groups permitted or excluded from using this medicine.

---

Populations Excluded from Use

Classification	Population/Condition
Contraindicated	Individuals with known hypersensitivity (allergy) to benzydamine hydrochloride or any of the product's excipients.
Contraindicated	Children under 6 years of age (specifically for lozenge forms).
Contraindicated	Use during the last trimester of pregnancy (for systemic forms).

Populations Requiring Caution or Conditional Use

Classification	Population/Condition
Conditional Use	Patients with a history of bronchial asthma or a predisposition to bronchospasm (requires caution).
Conditional Use	Patients with a known history of hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
Not Recommended	Women who are pregnant (first two trimesters) or breastfeeding, due to unestablished safety and unknown excretion into breast milk.
Conditional Use	Patients with severe renal impairment (requires caution due to systemic absorption and excretion).

---

Age-Related Eligibility: Use is generally allowed for adults and adolescents (typically over 12 years). Specific pediatric dosing and age cut-offs apply for different product forms (e.g., sprays or rinses may be allowed for children over 6 years at a modified dose).

Interactions with other medicines and products

Official regulatory information confirms that due to the topical oromucosal administration and low systemic absorption of Benzydamine Hydrochloride, the risk of clinically significant drug-drug interactions is considered minimal, and no relevant systemic interactions have been reported.

---

Documented Interaction Constraints

Category	Regulatory Statement
Systemic Medicines	No clinically relevant systemic drug-drug interactions are reported or anticipated.
Pharmacodynamic Risk	Not advised for use in patients with known hypersensitivity to acetylsalicylic acid (aspirin) or other NSAIDs due to a class-effect risk.
Local Restriction	Mouthwash and solution formulations must not be mixed with other medicinal products at the time of use.
Excipient Note	Liquid formulations contain ethanol (alcohol) as a non-active ingredient (excipient).
Population Caution	The possibility of systemic action must be considered in patients with renal impairment as Benzydamine is primarily excreted by the kidneys.

---

Interaction Profile Summary

This interaction profile is structured around class-specific safety warnings rather than metabolic or transporter-mediated interactions with systemic drugs. The constraints primarily involve a prohibition against mixing the local product with other medicines and an essential consideration for patients with impaired renal function due to the drug’s clearance pathway. This low-risk assessment stems from the drug's localized site of action, which limits the amount of active ingredient available for systemic interaction.

The action of Benzydamine Hydrochloride is defined by its multi-target mechanism, which simultaneously influences the processes of peripheral sensory signaling and local inflammatory modulation without relying heavily on the conventional anti-prostaglandin pathway of typical NSAIDs.

The primary physical mechanism for modulating peripheral sensory signaling involves Direct Blockade of Nociceptive Signals. The lipophilic molecule interacts directly with neuronal membranes and specifically blocks voltage-gated sodium channels (Na^+ channels) on peripheral nerve endings. This action physically prevents the generation of the electrical nerve impulse, leading to the physiological consequence of localized sensory transmission blockade.

The anti-inflammatory mechanism is achieved through Upstream Modulation of Inflammatory Mediator Production. Benzydamine functions as a modulator of early molecular signaling by inhibiting intracellular pathways, such as the p38 MAPK cascade. This leads to a substantial reduction in the synthesis and release of key pro-inflammatory cytokines, specifically Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-1 beta (IL-1beta). This modulates the inflammatory cascade by controlling initiating chemical messengers.

A secondary contribution involves Targeted Cellular and Lysosomal Membrane Stabilization. By maintaining high localized concentrations, Benzydamine physically stabilizes the membranes of immune cells, including neutrophils, thereby restricting the release of destructive enzymes and azurophilic granules. This specialized mechanism restricts the dissemination of lytic enzymes into the surrounding tissue, a process that is mechanistically independent of the typical prostaglandin synthesis inhibition seen with classic NSAIDs.

Oral Rinse (0.15% Benzydamine Hydrochloride)

Тантум (Benzydamine hydrochloride) oral rinse is a topical nonsteroidal anti-inflammatory drug (NSAID) with local analgesic properties, indicated for symptomatic relief of pain and inflammation in the mouth and throat, such as pharyngitis or radiation-associated mucositis.

Important Administration Guidelines:

• Do not swallow the rinse. The product is intended for gargling or rinsing only and should be expelled from the mouth after use.
• If the undiluted solution causes a stinging or burning sensation, it may be diluted with an equal volume of lukewarm water (1:1 ratio) prior to use.

Condition	Dose & Frequency	Instructions
Acute Sore Throat	15 mL every 1.5 to 3 hours, as needed.	Gargle or rinse the mouth for at least 30 seconds.
Radiation-Associated Mucositis	15 mL three to four times per day.	Begin treatment one day prior to radiation therapy and continue daily during and after treatment until relief is achieved. Rinse the mouth for at least 30 seconds.

Contraindications and Precautions:

Consult a healthcare professional if symptoms persist beyond a few days or worsen. The product is contraindicated in individuals with known hypersensitivity to benzydamine or other nonsteroidal anti-inflammatory drugs (NSAIDs). Use with caution in patients with severe renal impairment, as benzydamine is absorbed from the oral mucosa and excreted primarily in the urine.

Research Evidence / Overview of Studies for Тантум (Benzydamine)

Evidence Base for Acute Oropharyngeal Pain

The research base for the medicine includes studies involving its application for conditions associated with acute or disruptive episodes of discomfort in the throat, such as tonsillopharyngitis. The evidence is derived primarily from short-term Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that combine the findings from multiple studies. Research examined a large number of adult patients with recent onset of throat discomfort. These studies used in research exploring how symptoms change over time in the observed populations.

Researchers focused on patient-reported outcomes describing perceived discomfort, measured using standardized pain intensity scales, as well as the time until patients reported changes in their symptom levels. Trials consistently reported measurements of changes in short-term discomfort compared to inactive preparations (placebo) or against other topical treatments that were also studied. Findings describe patterns observed in the studies; onset of measured changes in discomfort were reported as occurring within the first hour after initial application.

Evidence Base for Prevention of Oral Mucositis

The research for this application examined a specific patient population: adults with head and neck cancer receiving radiation therapy. This research examined temporary physiological imbalance related to inflammation and was observed in studies conducted during periods of increased symptom activity (the radiation course).

Findings describe patterns where the frequency of the most severe inflammatory symptoms was lower in the observed populations compared to controls in this setting. This evidence contributes to the understanding of symptom patterns specifically for prevention in those receiving moderate-dose radiation therapy. The evidence base, including RCTs, has been used in reviews by major oncology support bodies to develop formal clinical guidelines.

Research Examining Follow-up Durations and Long-Term Outcomes

Research exploring short-term symptom changes is the most common, with typical follow-up durations being limited to the period of acute discomfort, usually between one and seven days. As a result, there is limited information for long-term outcomes or the durability of observed effects when the medicine is used repeatedly or continuously. Long-term effects are not fully established for any of the main applications.

Areas of Research Uncertainty and Study Gaps

Despite the volume of short-term RCTs, evidence quality varies across studies, and several areas remain where research is ongoing or still emerging. Comparative evidence is lacking in some contexts, and the full picture of how this preparation was studied against other relevant topical or systemic alternatives is not fully established. Key research gaps include the absence of extensive data on long-term consequences and the limited number of studies investigating its use when symptoms are secondary to certain complex medical conditions.

Key Studies & References

1. Benzydamine in the management of radiation-induced oropharyngeal mucositis: a randomized, double-blind, placebo-controlled clinical trial

Common questions about Тантум (FAQ)

Q: How long does the effect of Тантум last?

A: According to official product documentation, the pain-relieving effect following a single use is generally described as lasting for a few hours. The medicine is intended for localized action, providing temporary relief from pain and inflammation in the mouth and throat.

Q: What is the difference between Тантум Verde and regular Тантум?

A: Tantum Verde is simply a brand name under which the active ingredient, benzydamine, is sold in various regions. This means that Tantum Verde and regular Tantum products contain the same core medicine and are intended for the same general uses for the mouth and throat.

Q: Is Тантум available in different forms like lozenges, spray, or rinse?

A: Yes, the medicine is available in several forms for topical application to the mouth and throat. Official dosage forms typically include an oromucosal spray, an oral rinse solution (mouthwash or gargle), and lozenges.

Q: Can Тантум be used for a dry cough?

A: Official sources approve the use of the medicine for local pain and inflammation, such as pharyngitis. Regulatory information indicates that a cough is listed in some documents as a potential side effect, and the medicine is not indicated for treating cough itself.

Q: Can Тантум be used for pain after a dental procedure?

A: Yes, studies and regulatory documents describe the medicine's use for relief from pain and inflammation associated with dental procedures and oral surgery. Its localized anti-inflammatory and pain-relieving actions address temporary oral discomfort.

Q: Is Тантум safe to use during pregnancy?

A: Official product information indicates that use during pregnancy is not generally recommended unless a healthcare provider determines the potential benefits clearly outweigh the risks. Due to the lack of sufficient data, some regulatory documents list its use as restricted or contraindicated.

Q: Is Тантум safe to use while breastfeeding?

A: Official information indicates that the medicine is generally not recommended for use during lactation. Regulatory sources note that it is unknown whether the active substance passes into breast milk, and therefore, its use should only proceed if deemed essential by a physician.

Q: Can children of all ages use Тантум?

A: No, the medicine is not approved for children of all ages, and age restrictions vary based on the specific dosage form. For example, the oral rinse is often restricted for children under 13, and the spray may have different age or weight-based dosing requirements.

Q: Is there an age limit for using Тантум lozenges?

A: Regulatory documents state that lozenges are generally authorized for use by adults and children who are 6 years of age and over. For use in children, regulatory guidance specifies referring to the age instructions on the product label.

Q: What happens if I accidentally swallow some of the Тантум rinse?

A: The oral rinse is strictly intended to be expelled after gargling. While systemic absorption is typically low, regulatory documents state that in the event of an overdose or excessive swallowing, a poison control center should be contacted immediately.

Q: Are there any common foods or drinks that interact with Тантум?

A: Official guidance on the product indicates that you can generally eat and drink normally while using this medicine. The localized, topical application means that common foods and drinks do not typically interfere with the drug's action.

Q: Can Тантум be used at the same time as cold and flu medicine?

A: Since this medicine has low systemic absorption, no severe or serious drug interactions are reported with concurrent use of systemic cold and flu medications. Regulatory text emphasizes the importance of informing a healthcare professional about all medicines being taken.

Q: Is there a link between Тантум and stomach upset?

A: Yes, nausea, vomiting, and general stomach upset are listed in some regulatory documents as possible side effects of the medicine. These reactions are typically related to systemic absorption of the active ingredient.

Q: How many days in a row is it appropriate to use Тантум?

A: Official product information notes that uninterrupted treatment should generally not exceed 7 days. If symptoms persist or worsen after this period, regulatory guidance suggests stopping use.

Q: Does Тантум contain any sugar or alcohol?

A: Liquid forms, such as the oral rinse and spray, contain ethanol (alcohol) as a non-active ingredient or excipient. The lozenges typically use sugar substitutes, such as Sorbitol or Isomalt, instead of sugar.

Q: Is Тантум available over-the-counter or does it require a prescription?

A: The regulatory status of the product depends on the country. In some regions, it is available for purchase over-the-counter (OTC), while in other areas, it may require a formal prescription.

Q: What is the main difference between Тантум and local anesthetic sprays?

A: The primary distinction is the dual action of the active ingredient, benzydamine. It functions not only as a local anesthetic to numb the pain but also as an anti-inflammatory agent to manage swelling and redness, unlike pure local anesthetic products.

Q: Does Тантум interact with herbal supplements?

A: Regulatory safety information emphasizes the importance of disclosing all products being taken, including herbal supplements and natural remedies, to a healthcare professional. This allows for a full assessment of potential interactions.

Q: Is it appropriate to use Тантум after oral surgery?

A: The product is described in official sources for use in the relief of pain and inflammation associated with oral surgery and other dental procedures. Its localized action is described as suitable for treating temporary discomfort in the oral cavity.

Q: Is there an official maximum number of sprays or lozenges per day described?

A: Yes, official product information provides clear maximum use guidelines that vary by form. Lozenges typically have a maximum daily limit, and the spray has recommended application frequency limits within a set time frame.

Q: Can I use Тантум if I am taking blood thinners?

A: Due to the product's classification as a Non-Steroidal Anti-Inflammatory Drug (NSAID), regulatory guidance recommends informing a healthcare professional if blood thinners (anticoagulants) are being taken. This allows for a full review of any potential risks.

Q: Does Тантум have an effect on fever?

A: The active ingredient, benzydamine, is described in some official documents as having antipyretic properties, meaning it may contribute to fever reduction. However, its primary approved use is for local pain and inflammation.

Q: Is Тантум recommended for recurrent tonsillitis?

A: Studies have examined the medicine's use for tonsillopharyngitis, which involves inflammation of the tonsils. However, official sources do not provide specific recommendations or usage guidelines for chronic or recurrent tonsillitis.

Q: Why is Тантум sometimes prescribed by dentists?

A: Dentists may prescribe or recommend this medicine because its approved uses include the relief of pain and inflammation associated with dental procedures and related conditions. Its localized action is suitable for oral discomfort.

Q: Can Тантум be used by people with diabetes?

A: While the active ingredient itself is not widely restricted for people with diabetes, some dosage forms, such as lozenges, contain sugar substitutes like Isomalt. Regulatory guidance suggests that patients with diabetes may need to review the full excipient list on the product label.

Q: How does the spray get into the back of the throat effectively?

A: Regulatory documentation describes the spray administration method as holding the bottle upright and aiming the nozzle directly at the affected area. This technique ensures the mist reaches the sore area in the throat for effective topical action.

Q: Are there any known long-term side effects from using Тантум?

A: Official guidelines generally limit the use of the medicine to a short period (typically 7 days). Prolonged use carries a specific risk of developing local sensitisation. Long-term safety beyond the recommended acute duration is not fully established in regulatory sources.

Q: Can I use the Тантум lozenges and spray on the same day?

A: Official product information provides separate dosing guidelines for lozenges and the spray. While concurrent use of different forms is not explicitly prohibited, users are advised to adhere to the maximum daily limits specified for each product individually.

Q: Has Тантум been studied in older adult populations?

A: Yes, regulatory documents note that older adult patients can typically receive the same dose as adults for the oromucosal spray. This is based on the small amount of drug that is systemically absorbed through the topical route of administration.

Q: Can I use Тантум if I have a history of liver or kidney problems?

A: Caution is officially advised for patients with severe renal (kidney) impairment because the drug is primarily excreted by the kidneys. Regulatory guidance recommends informing a healthcare provider about any history of organ dysfunction.

Q: Does Тантум interact with alcohol consumption?

A: Official guidance generally states that it is acceptable to consume alcohol while using the product. This is due to its topical administration and minimal systemic absorption, which limits the risk of interaction.

Q: Is it normal for my throat to feel dry after using Тантум?

A: Yes, according to regulatory sources, dry mouth or dryness of the mouth with associated thirst is listed as a potential side effect of the medicine. This is a recognized occurrence that is noted as a possibility during use.

Q: Can Тантум be used for mouth ulcers or sores?

A: Yes, the medicine is indicated or described in regulatory documents for the symptomatic treatment of inflammatory conditions in the mouth, which includes mouth ulcers (aphthous ulcers) and sores.

Q: Are there different flavors of the lozenges available?

A: Official product information confirms that the lozenges are available in different flavors. Examples include Raspberry, Eucalyptus & Menthol, and Honey & Lemon flavors.

How to Store and Dispose of Tantum?

The storage and disposal of Tantum (Benzydamine) are subject to official regulatory requirements designed to maintain product quality and ensure safety.

Official Storage Constraints

Constraint	Requirement
Temperature Limit	Do not store above 25 C or 30 C (check specific product label).
Container Rule	Keep the container tightly closed and store in the original packaging to protect from moisture.
Stability Period	The oral solution must be used within 6 months of first opening (SmPC regulation).
Safety Rule	Keep out of the reach of children at all times.

Mandated Disposal Rules

Expired or unused Tantum must be discarded according to local regulatory requirements, often through a pharmacy or community collection program. It is an official environmental restriction that the product must not be thrown into the sewer or wastewater system to prevent aquatic contamination.